Innovation requires collaboration
Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.read more
What we do
Radboudumc receives grant from Nationaal Groeifonds Investments in Biotech Booster, Oncode-PACT and PharmaNL19 April 2022
The Nationaal Groeifonds awards large grants to three consortia of which the Radboudumc is a member. Oncode-PACT, PharmaNL and Biotech Booster will receive amounts ranging from 80 to 325 million euros.
Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm4 April 2022
Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides.